Effect of interleukin-1β treatment on co-cultures of human meniscus cells and bone marrow mesenchymal stromal cells

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Chowdhury, Anika ^a   Bezuidenhout, Louis W ^a   Mulet Sierra, Aillette ^a   Jomha, Nadr M ^a   Adesida, Adetola B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bone marrow stromal cells; Chondrogenesis; Co cultures; Fibrochondrogenesis; Meniscus; Meniscus cells; Tissue engineering

Indexed keywords

AGGRECAN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGENASE 3; DNA; GAG PROTEIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; REAGENT; RECOMBINANT INTERLEUKIN 1BETA; SAFRANIN O; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; BONE MARROW MESENCHYMAL STROMAL CELL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CHONDROGENESIS; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KNEE MENISCUS; MENISCUS CELL; MESENCHYMAL STROMA CELL; MONOCULTURE; ORGAN DONOR; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

BIOLOGICAL MARKERS; CELL SURVIVAL; CELLS, CULTURED; CHONDROGENESIS; COCULTURE TECHNIQUES; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HUMANS; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 1; MENISCI, TIBIAL; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84880334332     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-216     Document Type: Article

References (52)

1. The knee meniscus: Structure-function, pathophysiology, current repair techniques, and prospects for regeneration. Makris EA, Hadidi P, Athanasiou KA, Biomaterials 2011 32 30 7411 7431 10.1016/j.biomaterials.2011.06.037 21764438
2. The menisci of the knee joint. Anatomical and functional characteristics, and a rationale for clinical treatment. Messner K, Gao J, J Anat 1998 193 Pt 2 161 178 9827632 (Pubitemid 28479040)
3. The contribution of the menisci to the stabilty of the knee. Levy IM, Torzilli PA, Fisch ID, Knee Meniscus: Basic and Clinical Foundations New York: Raven Press, Ltd, Mow VC, Arnoczky SP, Jackson DW, 1992 107 115
4. The load-bearing role of the knee meniscus. Ahmed AM, Knee Meniscus: Basic and Clinical Foundations New York: Raven Press, Ltd, Mow VC, Arnoczky SP, Jackson DW, 1992 59 73
5. Function of the normal meniscus and consequences of meniscal resection. Aagaard H, Verdonk R, Scand J Med Sci Sports 1999 9 3 134 140 10380269
6. Reduced degenerative articular cartilage changes after meniscal allograft transplantation in sheep. Aagaard H, Jorgensen U, Bojsen-Moller F, Knee Surg Sports Traumatol Arthrosc 1999 7 3 184 191 10.1007/s001670050145 10401656
7. The extracellular matrix of the meniscus. Adams ME, Hukins DWL, Knee Meniscus: Basic and Clinical Foundations New York: Raven Press Ltd, Mow VC, Arnoczky SP, Jackson DW, 1992 15 28
8. The cells and cell matrix interactions of the meniscus. McDevitt CA, Miller RR, Spindler KP, Knee Meniscus: Basic and Clinical Foundations New York: Raven, Mow VC, Arnoczky SP, Jackson DW, 1992 29 36
9. Emerging concepts of the cell biology of the meniscus. McDevitt CA, Mukherjee S, Kambic H, Parker R, Curr Opin Orthop 2002 13 5 345 350 10.1097/00001433-200210000-00004
10. The consequences of meniscectomy. McDermott ID, Amis AA, J Bone Joint Surg Br 2006 88 12 1549 1556 17159163 (Pubitemid 44970679)
11. Knee osteoarthritis after meniscectomy: Prevalence of radiographic changes after twenty-one years, compared with matched controls. Roos H, Lauren M, Adalberth T, Roos EM, Jonsson K, Lohmander LS, Arthritis Rheum 1998 41 4 687 693 10.1002/1529-0131(199804)41:4<687::AID-ART16>3.0.CO;2-2 9550478 (Pubitemid 28214987)
12. Knee joint changes after menisectomy. Fairbank T, J Bone Joint Surg 1948 30B 664 670
13. Building a meniscus. Biologic considerations. Arnoczky SP, Clin Orthop 1999 367 Suppl 244 S253
14. Tissue engineered meniscus: a potential new alternative to allogeneic meniscus transplantation. Ibarra C, Jannetta C, Vacanti CA, Cao Y, Kim TH, Upton J, Vacanti JP, Transplant Proc 1997 29 1-2 986 988 9123618 (Pubitemid 27126054)
15. Tissue engineering meniscus: cells and matrix. Ibarra C, Koski JA, Warren RF, Orthop Clin North Am 2000 31 3 411 418 10.1016/S0030-5898(05)70160-7 10882467 (Pubitemid 30624515)
16. Tissue engineering with meniscus cells derived from surgical debris. Baker BM, Nathan AS, Huffman GR, Mauck RL, Osteoarthritis Cartilage 2009 17 3 336 345 10.1016/j.joca.2008.08.001 18848784
17. Meniscal repair using bone marrow-derived mesenchymal stem cells: experimental study using green fluorescent protein transgenic rats. Izuta Y, Ochi M, Adachi N, Deie M, Yamasaki T, Shinomiya R, Knee 2005 12 3 217 223 10.1016/j.knee.2001.06.001 15911296 (Pubitemid 40720230)
18. A study of polyvinyl alcohol-hydrogel (PVA-H) artificial meniscus in vivo. Kobayashi M, Biomed Mater Eng 2004 14 4 505 515 15472397 (Pubitemid 40916719)
19. Tissue engineering for total meniscal substitution: animal study in sheep model-results at 12 months. Kon E, Filardo G, Tschon M, Fini M, Giavaresi G, Reggiani LM, Chiari C, Nehrer S, Martin I, Salter DM, et al. Tissue Eng Part A 2012 18 15-16 1573 1582 22500654
20. Differential cartilaginous tissue formation by human synovial membrane, fat pad, meniscus cells and articular chondrocytes. Marsano A, Millward-Sadler SJ, Salter DM, Adesida A, Hardingham T, Tognana E, Kon E, Chiari-Grisar C, Nehrer S, Jakob M, et al. Osteoarthritis Cartilage 2007 15 1 48 58 10.1016/j.joca.2006.06.009 16891129 (Pubitemid 46117912)
21. Matrix formation is enhanced in co-cultures of human meniscus cells with bone marrow stromal cells. Matthies NF, Mulet-Sierra A, Jomha NM, Adesida AB, J Tissue Eng Regen Med 2012 In press
22. Regional multilineage differentiation potential of meniscal fibrochondrocytes: implications for meniscus repair. Mauck RL, Martinez-Diaz GJ, Yuan X, Tuan RS, Anat Rec (Hoboken) 2007 290 1 48 58 10.1002/ar.20419 (Pubitemid 46328083)
23. Meniscus cells seeded in type I and type II collagen-GAG matrices in vitro. Mueller SM, Shortkroff S, Schneider TO, Breinan HA, Yannas IV, Spector M, Biomaterials 1999 20 8 701 709 10.1016/S0142-9612(98)00189-6 10353653 (Pubitemid 29176699)
24. Human meniscus cell: characterization of the primary culture and use for tissue engineering. Nakata K, Shino K, Hamada M, Mae T, Miyama T, Shinjo H, Horibe S, Tada K, Ochi T, Yoshikawa H, Clin Orthop Relat Res 2001 391 Suppl 208 218
25. Repair of meniscal cartilage white zone tears using a stem cell/collagen-scaffold implant. Pabbruwe MB, Kafienah W, Tarlton JF, Mistry S, Fox DJ, Hollander AP, Biomaterials 2010 31 9 2583 2591 10.1016/j.biomaterials. 2009.12.023 20053438
26. Tissue engineering and regenerative medicine strategies in meniscus lesions. Pereira H, Frias AM, Oliveira JM, Espregueira-Mendes J, Reis RL, Arthroscopy 2011 27 12 1706 1719 10.1016/j.arthro.2011.08.283 22019234
27. Cell-based therapy for meniscal repair: a large animal study. Peretti GM, Gill TJ, Xu JW, Randolph MA, Morse KR, Zaleske DJ, Am J Sports Med 2004 32 1 146 158 10.1177/0095399703258790 14754738 (Pubitemid 38141436)
28. Tissue engineering of the meniscus. Buma P, Ramrattan NN, van Tienen TG, Veth RPH, Biomaterials 2004 25 9 1523 1532 10.1016/S0142-9612(03)00499-X 14697855 (Pubitemid 38091532)
29. A tissue engineering approach to meniscus regeneration in a sheep model. Chiari C, Koller U, Dorotka R, Eder C, Plasenzotti R, Lang S, Ambrosio L, Tognana E, Kon E, Salter D, et al. Osteoarthritis Cartilage 2006 14 10 1056 1065 10.1016/j.joca.2006.04.007 16731009 (Pubitemid 44309421)
30. Stem cell based tissue engineering for meniscus repair. Angele P, Johnstone B, Kujat R, Zellner J, Nerlich M, Goldberg V, Yoo J, J Biomed Mater Res A 2008 85 2 445 455 17729255 (Pubitemid 351535327)
31. Stem cell therapy in a caprine model of osteoarthritis. Murphy JM, Fink DJ, Hunziker EB, Barry FP, Arthritis Rheum 2003 48 12 3464 3474 10.1002/art.11365 14673997 (Pubitemid 37531912)
32. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Mueller MB, Tuan RS, Arthritis Rheum 2008 58 5 1377 1388 10.1002/art.23370 18438858 (Pubitemid 351705927)
33. Decreased hypertrophic differentiation accompanies enhanced matrix formation in co-cultures of outer meniscus cells with bone marrow mesenchymal stromal cells. Saliken DJ, Mulet-Sierra A, Jomha NM, Adesida AB, Arthritis Res Ther 2012 14 3 153 10.1186/ar3889 22726892
34. Structured three-dimensional co-culture of mesenchymal stem cells with meniscus cells promotes meniscal phenotype without hypertrophy. Cui X, Hasegawa A, Lotz M, D'Lima D, Biotechnol Bioeng 2012 109 9 2369 2380 10.1002/bit.24495 22422555
35. Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells. Adesida AB, Mulet-Sierra A, Jomha NM, Stem Cell Res Ther 2012 3 2 9 10.1186/scrt100 22385573
36. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. Acharya C, Adesida A, Zajac P, Mumme M, Riesle J, Martin I, Barbero A, J Cell Physiol 2012 227 88 97 10.1002/jcp.22706 22025108
37. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Farndale RW, Buttle DJ, Barrett AJ, Biochim Biophys Acta 1986 883 2 173 177 10.1016/0304-4165(86)90306-5 3091074 (Pubitemid 16027978)
38. Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: generation of scaffold-free cartilage. Murdoch AD, Grady LM, Ablett MP, Katopodi T, Meadows RS, Hardingham TE, Stem Cells 2007 25 11 2786 2796 10.1634/stemcells.2007-0374 17656642 (Pubitemid 350127863)
39. The matrix-forming phenotype of cultured human meniscus cells is enhanced after culture with fibroblast growth factor 2 and is further stimulated by hypoxia. Adesida AB, Grady LM, Khan WS, Hardingham TE, Arthritis Res Ther 2006 8 3 61 10.1186/ar1929 16563175
40. Human meniscus cells express hypoxia inducible factor-1alpha and increased SOX9 in response to low oxygen tension in cell aggregate culture. Adesida AB, Grady LM, Khan WS, Millward-Sadler SJ, Salter DM, Hardingham TE, Arthritis Res Ther 2007 9 4 69 10.1186/ar2267 17640365 (Pubitemid 47250409)
41. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta]CT method. Livak KJ, Schmittgen TD, Methods 2001 25 4 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
42. Response of human engineered cartilage based on articular or nasal chondrocytes to interleukin-1beta and low oxygen. Scotti C, Osmokrovic A, Wolf F, Miot S, Peretti GM, Barbero A, Martin I, Tissue Eng Part A 2012 18 3-4 362 372 21902467
43. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Le Maitre C, Hoyland J, Freemont A, Arthritis Res Ther 2007 9 4 83 10.1186/ar2282 17760968 (Pubitemid 47497183)
44. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG, Proc Natl Acad Sci USA 2007 104 26 11002 11007 10.1073/pnas.0704421104 17569781 (Pubitemid 47175216)
45. Intra-individual comparison of human ankle and knee chondrocytes in vitro: relevance for talar cartilage repair. Candrian C, Bonacina E, Frueh JA, Vonwil D, Dickinson S, Wirz D, Heberer M, Jakob M, Martin I, Barbero A, Osteoarthritis Cartilage 2009 17 4 489 496 10.1016/j.joca.2008.05.023 18980848
46. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2. Lemke AK, Sandy JD, Voigt H, Dreier R, Lee JH, Grodzinsky AJ, Mentlein R, Fay J, Schunke M, Kurz B, Cell Tissue Res 2010 340 1 179 188 10.1007/s00441-010-0941-4 20217136
47. Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art. Chen CZ, Raghunath M, Fibrogenesis Tissue Repair 2009 2 7 10.1186/1755-1536-2-7 20003476
48. Correlation of mRNA and protein in complex biological samples. Maier T, Güell M, Serrano L, FEBS Lett Syst Biol Nobel Symposium 146 2009 583 24 3966 3973
49. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. Majumdar MK, Wang E, Morris EA, J Cell Physiol 2001 189 3 275 284 10.1002/jcp.10025 11748585 (Pubitemid 33063295)
50. Effects of interleukin-1 on syntheses of alkaline phosphatase, type X collagen, and 1,25-dihydroxyvitamin D3 receptor, and matrix calcification in rabbit chondrocyte cultures. Kato Y, Nakashima K, Iwamoto M, Murakami H, Hiranuma H, Koike T, Suzuki F, Fuchihata H, Ikehara Y, Noshiro M, J Clin Invest 1993 92 5 2323 2330 10.1172/JCI116836 8227347 (Pubitemid 23333538)
51. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Sitcheran R, Cogswell PC, Baldwin AS Jr, Genes Dev 2003 17 19 2368 2373 10.1101/gad.1114503 14522944 (Pubitemid 37214785)
52. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Wehling N, Palmer GD, Pilapil C, Liu F, Wells JW, Muller PE, Evans CH, Porter RM, Arthritis Rheum 2009 60 3 801 812 10.1002/art.24352 19248089